Skip to main content
Fig. 3 | Renal Replacement Therapy

Fig. 3

From: Estimated influence of a novel biocompatible dialysis membrane on vascular events in dialysis patients with diabetic nephropathy: a prospective randomized controlled pilot study

Fig. 3

Change in the number of patients whose decrease in the width of the systolic blood pressure (SBP) drop was more than 20 mmHg. a TORAYLIGHT NV (NV) group. b Polysulfone (PS) group. White and black bars indicate number of patients whose decrease in the width of the SBP drop was less than or greater than 20 mmHg, respectively

Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us